USPTO serial 99551454
FRAGMENTIA-AI
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLONCH, ABIGAIL
- Law office
- TMO LAW OFFICE 114
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with FRAGMENTIA-AI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eunyoung Lee
Eunyoung Lee MONAMI LAW GROUP PLLC816A Ambrose Ln.MANASSAS PARK, VA 20111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for assisting in disease detection, monitoring, and treatment response evaluation; Downloadable computer software for data processing, feature extraction, and pattern recognition in medical and scientific research; Downloadable computer software using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing data; Recorded computer programs using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing data | ACTIVE | — |
| 042 | Providing temporary use of on-line non-downloadable software for research and clinical data analysis; Scientific and technological services, namely, research, development, and data analytics in the field of genomics, oncology, and artificial intelligence; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the analysis and interpretation of biological, genomic, and sequencing data | ACTIVE | — |
| 044 | Medical services, namely, diagnostic testing and analysis services using artificial intelligence for detecting and monitoring disease, evaluating treatment response, and supporting clinical decision-making | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 18, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 20, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 20, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 20, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2025 | NWAP | NEW APPLICATION ENTERED | — |